Cargando…

Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America

INTRODUCTION: We compared the performance of real-time PCR with culture-based methods for identifying bacteria in sputum samples from patients with chronic obstructive pulmonary disease (COPD) in three studies. METHODS: This was an exploratory analysis of sputum samples collected during an observati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoonbroodt, Sonia, Ichanté, Jean-Laurent, Boffé, Sophie, Devos, Nathalie, Devaster, Jeanne-Marie, Taddei, Laura, Rondini, Simona, Arora, Ashwani Kumar, Pascal, Thierry, Malvaux, Ludovic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000296/
https://www.ncbi.nlm.nih.gov/pubmed/36909845
http://dx.doi.org/10.3389/fmicb.2022.1098133
_version_ 1784903839952928768
author Schoonbroodt, Sonia
Ichanté, Jean-Laurent
Boffé, Sophie
Devos, Nathalie
Devaster, Jeanne-Marie
Taddei, Laura
Rondini, Simona
Arora, Ashwani Kumar
Pascal, Thierry
Malvaux, Ludovic
author_facet Schoonbroodt, Sonia
Ichanté, Jean-Laurent
Boffé, Sophie
Devos, Nathalie
Devaster, Jeanne-Marie
Taddei, Laura
Rondini, Simona
Arora, Ashwani Kumar
Pascal, Thierry
Malvaux, Ludovic
author_sort Schoonbroodt, Sonia
collection PubMed
description INTRODUCTION: We compared the performance of real-time PCR with culture-based methods for identifying bacteria in sputum samples from patients with chronic obstructive pulmonary disease (COPD) in three studies. METHODS: This was an exploratory analysis of sputum samples collected during an observational study of 127 patients (AERIS; NCT01360398), phase 2 study of 145 patients (NTHI-004; NCT02075541), and phase 2b study of 606 patients (NTHI-MCAT-002; NCT03281876). Bacteria were identified by culture-based microbiological methods in local laboratories using fresh samples or by real-time PCR in a central laboratory using frozen samples. Haemophilus influenzae positivity with culture was differentiated from H. haemolyticus positivity by microarray analysis or PCR. The feasibility of bacterial detection by culture-based methods on previously frozen samples was also examined in the NTHI-004 study. RESULTS: Bacterial detection results from both culture-based and PCR assays were available from 2,293 samples from AERIS, 974 from the NTHI-004 study, and 1736 from the NTHI-MCAT-002 study. Quantitative real-time PCR (qPCR) showed higher positivity rates than culture for H. influenzae (percentages for each study: 43.4% versus 26.2%, 47.1% versus 23.6%, 32.7% versus 10.4%) and Moraxella catarrhalis (12.9% versus 6.3%, 19.0% versus 6.0%, 15.5% versus 4.1%). In the NTHI-004 and NTHI-MCAT-002 studies, positivity rates were higher with qPCR for Streptococcus pneumoniae (15.6% versus 6.1%, 15.5% versus 3.8%); in AERIS, a lower rate with qPCR than with culture (11.0% versus 17.4%) was explained by misidentification of S. pseudopneumoniae/mitis isolates via conventional microbiological methods. Concordance analysis showed lowest overall agreement for H. influenzae (82.0%, 75.6%, 77.6%), due mainly to culture-negative/qPCR-positive samples, indicating lower sensitivity of the culture-based methods. The lowest positive agreement (culture-positive/qPCR-positive samples) was observed for S. pneumoniae (35.1%, 71.2%, 71.2%). Bacterial load values for each species showed a proportion of culture-negative samples with a load detected by qPCR; for some samples, the loads were in line with those observed in culture-positive samples. In the NTHI-004 study, of fresh samples that tested culture-positive, less than 50% remained culture-positive when tested from freeze/thawed samples. In the NTHI-004 study, of fresh samples that tested culture-positive, less than 50% remained culture-positive when tested from freeze/thawed samples. DISCUSSION: Real-time PCR on frozen sputum samples has enhanced sensitivity and specificity over culture-based methods, supporting its use for the identification of common respiratory bacterial species in patients with COPD.
format Online
Article
Text
id pubmed-10000296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100002962023-03-11 Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America Schoonbroodt, Sonia Ichanté, Jean-Laurent Boffé, Sophie Devos, Nathalie Devaster, Jeanne-Marie Taddei, Laura Rondini, Simona Arora, Ashwani Kumar Pascal, Thierry Malvaux, Ludovic Front Microbiol Microbiology INTRODUCTION: We compared the performance of real-time PCR with culture-based methods for identifying bacteria in sputum samples from patients with chronic obstructive pulmonary disease (COPD) in three studies. METHODS: This was an exploratory analysis of sputum samples collected during an observational study of 127 patients (AERIS; NCT01360398), phase 2 study of 145 patients (NTHI-004; NCT02075541), and phase 2b study of 606 patients (NTHI-MCAT-002; NCT03281876). Bacteria were identified by culture-based microbiological methods in local laboratories using fresh samples or by real-time PCR in a central laboratory using frozen samples. Haemophilus influenzae positivity with culture was differentiated from H. haemolyticus positivity by microarray analysis or PCR. The feasibility of bacterial detection by culture-based methods on previously frozen samples was also examined in the NTHI-004 study. RESULTS: Bacterial detection results from both culture-based and PCR assays were available from 2,293 samples from AERIS, 974 from the NTHI-004 study, and 1736 from the NTHI-MCAT-002 study. Quantitative real-time PCR (qPCR) showed higher positivity rates than culture for H. influenzae (percentages for each study: 43.4% versus 26.2%, 47.1% versus 23.6%, 32.7% versus 10.4%) and Moraxella catarrhalis (12.9% versus 6.3%, 19.0% versus 6.0%, 15.5% versus 4.1%). In the NTHI-004 and NTHI-MCAT-002 studies, positivity rates were higher with qPCR for Streptococcus pneumoniae (15.6% versus 6.1%, 15.5% versus 3.8%); in AERIS, a lower rate with qPCR than with culture (11.0% versus 17.4%) was explained by misidentification of S. pseudopneumoniae/mitis isolates via conventional microbiological methods. Concordance analysis showed lowest overall agreement for H. influenzae (82.0%, 75.6%, 77.6%), due mainly to culture-negative/qPCR-positive samples, indicating lower sensitivity of the culture-based methods. The lowest positive agreement (culture-positive/qPCR-positive samples) was observed for S. pneumoniae (35.1%, 71.2%, 71.2%). Bacterial load values for each species showed a proportion of culture-negative samples with a load detected by qPCR; for some samples, the loads were in line with those observed in culture-positive samples. In the NTHI-004 study, of fresh samples that tested culture-positive, less than 50% remained culture-positive when tested from freeze/thawed samples. In the NTHI-004 study, of fresh samples that tested culture-positive, less than 50% remained culture-positive when tested from freeze/thawed samples. DISCUSSION: Real-time PCR on frozen sputum samples has enhanced sensitivity and specificity over culture-based methods, supporting its use for the identification of common respiratory bacterial species in patients with COPD. Frontiers Media S.A. 2023-02-24 /pmc/articles/PMC10000296/ /pubmed/36909845 http://dx.doi.org/10.3389/fmicb.2022.1098133 Text en Malvaux, Schoonbroodt, Ichanté, Boffé, Devos, Devaster, Taddei, Rondini, Arora and Pascal, © 2023 GSK. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Schoonbroodt, Sonia
Ichanté, Jean-Laurent
Boffé, Sophie
Devos, Nathalie
Devaster, Jeanne-Marie
Taddei, Laura
Rondini, Simona
Arora, Ashwani Kumar
Pascal, Thierry
Malvaux, Ludovic
Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
title Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
title_full Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
title_fullStr Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
title_full_unstemmed Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
title_short Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
title_sort real-time pcr has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: results from three clinical studies in europe and north america
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000296/
https://www.ncbi.nlm.nih.gov/pubmed/36909845
http://dx.doi.org/10.3389/fmicb.2022.1098133
work_keys_str_mv AT schoonbroodtsonia realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT ichantejeanlaurent realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT boffesophie realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT devosnathalie realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT devasterjeannemarie realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT taddeilaura realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT rondinisimona realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT aroraashwanikumar realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT pascalthierry realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica
AT malvauxludovic realtimepcrhasadvantagesoverculturebasedmethodsinidentifyingmajorairwaybacterialpathogensinchronicobstructivepulmonarydiseaseresultsfromthreeclinicalstudiesineuropeandnorthamerica